Komori
Fureasu (7062) · RiskRestated

Revisions to Medical Treatment Reimbursements and Long-Term Care Fees and Legal Compliance

First written in FY2019. 6 of 10 entries say "Restated". Latest entry: 2026-08-14.

10entries
8years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY20252019: 120192020: 120202021: 020212022: 120222023: 120232024: 220242025: 120252026: 32026
Same theme, other companies

The whole theme swung hardest in 2026: 7 of 16 companies on the "Worse" side.

7 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 19 companies compared. The sentences above are computed from all 19.
Full recordFilings, disclosures and news, newest first
  1. 2026-08-14RestatedEarnings

    「For medical fees related to services provided by acupuncturists, moxibustion practitioners, and anma massage and shiatsu practitioners, a revision effective for services provided on or after 1 July 2026 has been applied, with a revision rate of +0.60%. While initial examination fees and treatment fees were increased and additional billing items for home-visit services were introduced, the declining reimbursement schedule based on the number of treatments was also revised. These changes did not affect results for the first quarter of the current consolidated fiscal year but may affect results from the second quarter onward.」

    This describes the specific details of the medical fee revision and the possibility of an impact on results from the second quarter onward.
  2. FY2026RestatedAnnual report

    「Medical treatment reimbursement and other fees under the medical insurance system are generally revised every 2 years, while long-term care fees under the long-term care insurance system are generally revised every 3 years.」

    The Company reiterates the regular revisions to medical treatment reimbursement and long-term care fees, and the risk that downward revisions could reduce service fees per treatment and revenue.
  3. 2026-05-29AdvancedPresentation materials on financial results

    「We confirm with the attending physician the physical condition and needs of each resident and determine the appropriate number of personnel.」

    This specifically describes the procedures for determining the number and frequency of home-visit nursing staff visits, including confirmation by the attending physician and proper insurance claims.
  4. FY2025Cumulative increase in treatment fees per service following the subsequent medical treatment reimbursement revisionAnnual report

    「In the Company's company-operated and franchise massage businesses, fees per treatment have increased since June 2024 following revisions to medical treatment reimbursement for services provided by acupuncturists, moxibustion practitioners, and massage and shiatsu practitioners.」

    The June 2024 revision to medical treatment reimbursement increased fees per treatment. Although the October 2024 subsequent revision resulted in a slight decrease, fees per treatment increased overall, the Company states.
  5. FY2025-H1Increase in treatment fees per service following a revision to medical treatment reimbursementAnnual report

    「In the Company's company-operated and franchise massage businesses, fees per treatment have increased since June 2024 following revisions to medical treatment reimbursement for services provided by acupuncturists, moxibustion practitioners, and massage and shiatsu practitioners.」

    Regarding the revision to medical treatment reimbursement, the Company reports that fees per treatment increased during the interim period.
  6. FY2024RestatedAnnual report

    「Medical treatment reimbursement and other fees under the medical insurance system are generally revised every 2 years, while long-term care fees under the long-term care insurance system are generally revised every 3 years.」

    The Company reiterates the regular revisions to medical treatment reimbursement and long-term care fees, and the risk that downward revisions could reduce fees per service and revenue.
  7. FY2023RestatedAnnual report

    「Medical treatment reimbursement and other fees under the medical insurance system are generally revised every 2 years, while long-term care fees under the long-term care insurance system are generally revised every 3 years.」

    The Company reiterates the regular revisions to medical treatment reimbursement and long-term care fees, and the risk that downward revisions could reduce fees per service and revenue.
  8. FY2022RestatedAnnual report

    「Medical treatment reimbursement and other fees under the medical insurance system are generally revised every 2 years, while long-term care fees under the long-term care insurance system are generally revised every 3 years.」

    The Company reiterates the regular revisions to medical treatment reimbursement and long-term care fees, and the risk that downward revisions could reduce fees per service and revenue.
  9. FY2020RestatedAnnual report

    「Medical treatment reimbursement and other fees under the medical insurance system are generally revised every 2 years, while long-term care fees under the long-term care insurance system are generally revised every 3 years.」

    The Company reiterates the regular revisions to medical treatment reimbursement and long-term care fees, and the risk that downward revisions could reduce fees per service and revenue.
  10. FY2019First statedAnnual report

    「Medical treatment reimbursement and other fees under the medical insurance system are generally revised every 2 years, while long-term care fees under the long-term care insurance system are generally revised every 3 years. The Company operates its business with due attention to these system revisions. However, if the social security system is reviewed as the aging of society progresses further and treatment fees and other charges are revised downward, lower service fees per treatment could reduce revenue and have a material impact on the Company's operating results and financial condition.」

    The Company describes the revision cycles for these fees and the possibility that downward revisions could reduce fees per service and revenue.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Fureasu yet. It last moved in the Earnings of 2026-08-14: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Revisions to Medical Treatment Reimbursements and Long-Term Care Fees and Legal Compliance | Fureasu Co.,Ltd. (7062) | Komori